Irvine Scientific Announces Expansion of BalanCD™ Product Line to Serve Vaccine Market Irvine Scientific is pleased to announce the launch of its BalanCD™ MDCK cell culture medium, a next generation cell culture product responding to today’s requirements for media used in cell-based vaccine manufacturing.
April 15, 2014 - Business Wire via Yahoo! Finance